In the News
An analytical approach to biosimilar drug development
Patricia Hurley, Edward Tabler and Duu-Gong Wu talk about the impact that analytical testing on biosimilars has on their pathway to regulatory approval.
An interview with PPD
Rhonda Henry discusses some of the patient recruitment issues facing the clinical trials industry.
Challenging the ‘site-first’ status quo in patient enrollment
Tammy D’Lugin-Monroe and Dan Brunwasser highlight a new patient-centric enrollment model that uses a data-driven approach to identify qualified patients first.
Patient centricity: Moving from a ‘nice to have’ to best practice
Rhonda Henry discusses the concept of putting the patient “front and center.”
PPD flips the patient enrollment model and launches new site solution
Roger Smith discusses how SynexusPlus and PatientAdvantage will enhance PPD’s enrollment capabilities.
Synexus launches new patient registry to support longitudinal brain aging study
Dawie Wessels explains that Synexus is looking to register 30,000 adults for the five-year study focused on identifying potential prevention methods and possible treatments for Alzheimer’s and other dementias.
Synexus debuts new patient registry in U.S. for study of longitudinal brain aging
Synexus is collaborating with the University of Exeter in the U.K. to launch a registry-based study in the U.S. to better understand how healthy brains age.
PPD updates central lab tech, launches new app for investigator portal
Christopher Fikry explains how the over-arching purpose of the enhancements will improve the user experience for the company’s clients and investigative sites.
Emerging Technology Integration in FDA’s Drug Approval Process
Monika Jain and Shilpa Rana discuss the FDA’s “Emerging Technology Program.”
